Skip to main content
Clinical Trials/CTRI/2023/09/057791
CTRI/2023/09/057791
Not yet recruiting
Phase 3

Comparative study of treatment outcomes of patients of aplastic anemia with combination therapy cyclosporine A + danazol + eltrombopag vs cyclosporine A + danazol + high dose Romiplostim

Government of Uttar Pradesh0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: D619- Aplastic anemia, unspecified
Sponsor
Government of Uttar Pradesh
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Government of Uttar Pradesh

Eligibility Criteria

Inclusion Criteria

  • 1\. Confirmed cases of Aplastic anemia
  • 2\. Patient age \>15years
  • 3\. Not willing for ASCT and ATG.
  • 4\. Non\- pregnant women.
  • 5\. Those who consent to take part in the study.
  • 6\. No hepatic or renal disease.
  • 7\. No drug h/o that causes Myelo\-suppression.

Exclusion Criteria

  • 1\. Previous history of HSCT,
  • 2\. Patients eligible for HSCT
  • 3\. Patients with HIV/ HCV/ HBV infections.
  • 4\. Significant PNH clone and Myelodysplasia.

Outcomes

Primary Outcomes

Not specified

Similar Trials